KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Novavax (NVAX) Return on Assets: 2010-2025

Historic Return on Assets for Novavax (NVAX) over the last 14 years, with Sep 2025 value amounting to 0.27%.

  • Novavax's Return on Assets rose 43.00% to 0.27% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.27%, marking a year-over-year increase of 43.00%. This contributed to the annual value of -0.11% for FY2024, which is 16.00% up from last year.
  • Per Novavax's latest filing, its Return on Assets stood at 0.27% for Q3 2025, which was down 15.54% from 0.32% recorded in Q2 2025.
  • Novavax's 5-year Return on Assets high stood at 0.34% for Q1 2025, and its period low was -0.68% during Q4 2021.
  • For the 3-year period, Novavax's Return on Assets averaged around -0.13%, with its median value being -0.19% (2024).
  • In the last 5 years, Novavax's Return on Assets plummeted by 35bps in 2021 and then surged by 59bps in 2025.
  • Over the past 5 years, Novavax's Return on Assets (Quarterly) stood at -0.68% in 2021, then surged by 39bps to -0.29% in 2022, then fell by 2bps to -0.32% in 2023, then increased by 20bps to -0.11% in 2024, then skyrocketed by 43bps to 0.27% in 2025.
  • Its last three reported values are 0.27% in Q3 2025, 0.32% for Q2 2025, and 0.34% during Q1 2025.